ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,001 | 44.05197 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 26 | 121,420.875 | 92,187.5 | null | 51 | white | 38.398438 | 68 | 0.432983 | 0.312988 | 6 | 0 | 0 | no | null | null | no dnr | 5 | 51 | 9.898438 | 60 | 31 | 40.09375 | 283.3125 | 3.299805 | 12 | 3 | 133 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,002 | 70.14899 | 1 | female | 1 | 4 | 4 | Coma | Coma | 1 | 7 | null | 100 | 83,997.625 | 51,037.4375 | null | 14 | white | 22.699219 | 43 | 0.097992 | 0.058998 | 20 | 1 | 0 | no | null | null | dnr after sadm | 2 | 70 | 16.597656 | 64 | 28 | 38.5 | 220 | 2.5 | 1.099854 | 2.699707 | 135 | 7.579102 | null | null | null | null | null | <2 mo. follow-up | 2.46875 |
4,003 | 69.66498 | 0 | female | 0 | 9 | 1,510 | COPD | COPD/CHF/Cirrhosis | 3 | 11 | null | 0 | 4,562.496 | 3,465.2734 | null | 10 | white | 17.597656 | 34 | 0.868896 | 0.782959 | 1 | 0 | 0 | no | 0.75 | 0.65 | no dnr | 9 | 107 | 9.599609 | 84 | 22 | 36.39844 | 214.28125 | 3.399902 | 0.299988 | 1.599854 | 136 | null | null | null | null | 0 | null | null | 0.4948 |
4,004 | 65.47296 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 100 | 87,248.375 | 54,247.8438 | null | 23 | white | 76.6875 | 86 | 0 | 0 | 21 | 0 | 0 | no | null | null | dnr after sadm | 2 | 0 | 11.898438 | 0 | 0 | 38.09375 | 248 | 4.099609 | 4.5 | 2.599609 | 135 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 1.738281 |
4,005 | 68.18097 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 40,095 | 26,610 | null | 37.5 | white | 32.695313 | 55 | 0.555908 | 0.442993 | 1 | 0 | 0 | yes | 0.25 | 0.15 | dnr after sadm | 7 | 69 | 29.597656 | 122 | 34 | 36.79688 | 72 | 1.399902 | null | 0.699951 | 139 | 7.539062 | null | null | null | null | null | <2 mo. follow-up | 2.14502 |
4,006 | 75.15399 | 1 | male | 0 | 9 | 1,421 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 6,329.598 | 4,483.8203 | null | 13 | white | 14 | 13 | 0.880981 | 0.800903 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 9 | 107 | 5.5 | 108 | 24 | 36 | 364 | 4.299805 | 0.399963 | 0.899902 | 144 | 7.359375 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
4,007 | 65.42395 | 0 | female | 0 | 13 | 1,500 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 14 | $11-$25k | 0 | 9,626.047 | 7,334.457 | null | 7.5 | white | 23.398438 | 23 | 0.69397 | 0.529907 | 1 | 0 | 0 | no | null | null | no dnr | 13 | 77 | 3.599609 | 80 | 20 | 37 | null | 2.899902 | 3.5 | 0.699951 | 124 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
4,008 | 72.79095 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | null | 44 | 26,893.812 | 17,477.2656 | null | 46 | white | 32.296875 | 49 | 0.40094 | 0.280945 | 1 | 0 | 0 | no | null | null | dnr after sadm | 4 | 68 | 22.296875 | 112 | 8 | 38.79688 | 151.65625 | null | 0.099991 | 7.299805 | 128 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 2.412598 |
4,009 | 66.146 | 1 | male | 1 | 12 | 12 | MOSF w/Malig | ARF/MOSF | 2 | 7 | null | 0 | 71,331.938 | 46,761.8438 | null | 55.5 | black | 42 | 79 | 0.142975 | 0.066986 | 6 | 1 | 0 | yes | null | null | dnr after sadm | 5 | 53 | 1 | 160 | 40 | 36.5 | 313.3125 | 3 | 1.099854 | 5.299805 | 134 | 7.349609 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
4,010 | 74.89697 | 0 | male | 0 | 10 | 1,499 | CHF | COPD/CHF/Cirrhosis | 1 | 18 | $11-$25k | 0 | 23,341.547 | 16,540.5312 | null | 20 | white | 26.796875 | 36 | 0.657959 | 0.481995 | 8 | 0 | 0 | no | 0.98 | 0.95 | no dnr | 10 | 75 | 14.398438 | 96 | 12 | 36.59375 | 288 | 2.899902 | 1.199951 | 1.599854 | 131 | 7.429688 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,011 | 60.241 | 0 | female | 0 | 9 | 1,497 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 0 | 59,781.688 | 37,313 | null | 16.5 | white | 23 | 25 | 0.640991 | 0.539917 | 15 | 0 | 0 | yes | 0.8 | 0.7 | no dnr | 9 | 108 | 7 | 46 | 16 | 36.19531 | 396 | 1.299805 | 0.299988 | 0.599976 | 129 | 7.449219 | null | null | null | 0 | null | null | 0.4948 |
4,012 | 51.85498 | 0 | female | 0 | 14 | 1,497 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $25-$50k | 0 | 24,805.141 | 16,157.6328 | null | 14 | white | 21.398438 | 14 | 0.873901 | 0.829956 | 1 | 0 | 0 | no | null | null | no dnr | 14 | 76 | 8.5 | 114 | 24 | 36.19531 | 328 | null | null | 0.5 | 137 | 7.399414 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
4,013 | 43.63898 | 0 | male | 0 | 18 | 1,496 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 45,775.469 | 28,687.6094 | null | 18.666656 | white | 19.296875 | 16 | 0.907959 | 0.875 | 1 | 0 | 0 | no | null | null | no dnr | 18 | 78 | 7 | 56 | 24 | 36 | 352.375 | 2.899902 | 2.099609 | 0.799927 | 139 | 7.419922 | null | null | null | null | null | null | 2.197754 |
4,014 | 40.41898 | 1 | female | 1 | 99 | 99 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | $25-$50k | 0 | 363,470.25 | 238,485.375 | null | 34.75 | white | 34.695313 | 53 | 0.727905 | 0.644897 | 1 | 0 | 0 | no | 0.2 | 0.2 | no dnr | 99 | 69 | 14 | 114 | 26 | 37.79688 | 126.65625 | null | 1.199951 | 3.399902 | 149 | 7.469727 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,015 | 33.66998 | 1 | male | 0 | 10 | 22 | Colon Cancer | Cancer | 1 | 14 | null | 0 | 9,953.547 | 6,871.8125 | null | 9.5 | black | 26 | 9 | 0.743896 | 0.47998 | 1 | 0 | 0 | metastatic | 0.2 | 0.1 | no dnr | 10 | 107 | 17.199219 | 84 | 24 | 36.29688 | null | 2.699707 | 0.799927 | 0.799927 | 137 | null | null | null | null | 1 | 6 | <2 mo. follow-up | 6 |
4,016 | 75.66595 | 1 | female | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | $25-$50k | 26 | 60,396.969 | 37,721.1875 | null | 48 | white | 18.898438 | 33 | 0.776978 | 0.703979 | 1 | 0 | 0 | no | null | null | dnr after sadm | 13 | 71 | 8.5 | 64 | 40 | 38.59375 | 194.28125 | 2.199707 | null | 0.599976 | 138 | 7.369141 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
4,017 | 44.85999 | 1 | male | 0 | 9 | 26 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | under $11k | 44 | 27,579.141 | 17,868.6094 | null | 39 | black | 33.796875 | 43 | 0.519897 | 0.403992 | 2 | 0 | 0 | no | null | null | no dnr | 9 | 141 | 11.599609 | 116 | 60 | 35.39844 | 447.5625 | null | null | 0.399963 | 130 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,018 | 51.90097 | 1 | male | 0 | 6 | 517 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 12,283.992 | 7,625.2305 | null | 27 | black | 24.699219 | 23 | 0.849976 | 0.75293 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 6 | 65 | 7.199219 | 64 | 26 | 36.29688 | 385.6875 | 3.199707 | 1.699951 | 1 | 126 | 7.5 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,019 | 69.06799 | 1 | male | 1 | 36 | 36 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 26 | 238,776 | 149,039.25 | null | 39 | white | 29.296875 | 51 | 0.506958 | 0.389954 | 9 | 0 | 0 | no | 0.25 | 0.2 | no dnr | 36 | 120 | 19.296875 | 110 | 25 | 38.29688 | 303.3125 | 2.799805 | 5.599609 | 7 | 138 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,020 | 30.70499 | 1 | female | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | under $11k | 37 | 71,635.188 | 48,012.9375 | null | 50.333313 | other | 34.59375 | 60 | 0.641968 | 0.540894 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 15 | 70 | 13.699219 | 156 | 36 | 41 | 125 | 2.899902 | 1.299805 | 1.599854 | 145 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,021 | 52.57498 | 1 | male | 0 | 4 | 78 | Lung Cancer | Cancer | 1 | null | null | 0 | 3,042.049 | 2,174.0625 | null | 7 | white | 14.699219 | 9 | 0.775879 | 0.533936 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 4 | 115 | 12.199219 | 84 | 20 | 36.89844 | null | null | 0.799927 | 1.099854 | 139 | null | null | null | null | null | null | adl>=4 (>=5 if sur) | 1.958984 |
4,022 | 59.69598 | 0 | male | 0 | 4 | 1,488 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 2,390.049 | 1,955.835 | null | 3 | black | 27.5 | 32 | 0.782959 | 0.652954 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 87 | 5.5 | 110 | 20 | 35.69531 | 433.3125 | null | 4.199219 | 1.399902 | 129 | 7.519531 | null | null | null | 0 | null | null | 0.4948 |
4,023 | 65.62598 | 1 | male | 0 | 18 | 626 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 53,957.688 | 33,482.8438 | null | 32 | black | 26.296875 | 22 | 0.779907 | 0.648926 | 1 | 0 | 0 | no | null | null | no dnr | 18 | 109 | 11.798828 | 60 | 10 | 36.79688 | 142 | null | null | 1.299805 | 128 | 7.469727 | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
4,024 | 62.30298 | 1 | male | 0 | 11 | 758 | COPD | COPD/CHF/Cirrhosis | 2 | 11 | null | 0 | 24,865.984 | 15,584.4922 | null | 22 | white | 21.199219 | 31 | 0.86499 | 0.775879 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 11 | 67 | null | 108 | 16 | 37 | 312 | null | 0.5 | 2.199707 | 136 | 7.40918 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
4,025 | 48.72299 | 0 | female | 0 | 32 | 1,488 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 44 | 115,659.5 | 75,410.1875 | null | 35.25 | black | 30.097656 | 53 | 0.61792 | 0.513916 | 1 | 1 | 0 | no | 0.25 | 0.2 | no dnr | 32 | 55 | 4.099609 | 130 | 14 | 39.79688 | 288 | 2.799805 | 0.199982 | 10 | 145 | 7.439453 | null | null | null | null | 0 | null | 0 |
4,026 | 79.80798 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 13 | >$50k | 0 | 30,417.844 | 21,071.0312 | null | 42 | white | 25.699219 | 40 | 0.659912 | 0.56189 | 1 | 1 | 0 | yes | 0.5 | 0.25 | dnr after sadm | 3 | 64 | 13.398438 | 50 | 6 | 37.5 | 310 | 2.5 | null | 5.099609 | 133 | 7.359375 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
4,027 | 55.64999 | 1 | female | 0 | 37 | 777 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 37 | 92,960.125 | 59,123.4375 | null | 31.5 | white | 24.898438 | 43 | 0.721924 | 0.635986 | 1 | 1 | 0 | no | 0.8 | 0.78 | no dnr | 37 | 63 | 17.296875 | 110 | 24 | 38 | 253.3125 | null | 0.399963 | 4.599609 | 143 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,028 | 45.57397 | 0 | female | 0 | 15 | 1,487 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $25-$50k | 0 | 34,929.969 | 22,198.3594 | null | 12.333328 | black | 26.296875 | 17 | 0.816895 | 0.755981 | 3 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 15 | 80 | 12.699219 | 104 | 40 | 38.59375 | 316.625 | null | null | 0.599976 | 128 | 7.429688 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
4,029 | 52.16199 | 1 | male | 0 | 5 | 284 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 4,945.75 | 3,090.332 | null | 17 | white | 15.898438 | 11 | 0.755981 | 0.5 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 107 | 10 | 75 | 16 | 35.79688 | null | null | 0.399963 | 0.899902 | 142 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,030 | 73.52795 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 44,709.406 | 26,464.9844 | null | 37 | white | 31.597656 | 44 | 0.557983 | 0.444946 | 6 | 1 | 0 | no | 0.2 | 0.1 | dnr after sadm | 3 | 51 | 9.5 | 114 | 30 | 39.09375 | 162.5 | null | null | 1.199951 | 154 | 7.339844 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
4,031 | 61.37399 | 1 | male | 0 | 4 | 40 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 3,351.299 | 2,423.291 | null | 4 | white | 20 | 13 | 0.780884 | 0.540894 | 1 | 0 | 0 | metastatic | 0.4 | 0.3 | no dnr | 4 | 83 | 14.099609 | 75 | 16 | 35.69531 | 342.8125 | null | 1.699951 | 0.599976 | 140 | 7.489258 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
4,032 | 66.52698 | 1 | female | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 26 | 82,417.812 | 52,280.0625 | null | 50.666657 | white | 33.296875 | 42 | 0.419983 | 0.300964 | 1 | 0 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 8 | 50 | 8.699219 | 110 | 25 | 35.69531 | 111.65625 | 2.699707 | 0.299988 | 1.099854 | 141 | 7.339844 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
4,033 | 59.60599 | 0 | male | 0 | 75 | 1,483 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 142,387.875 | 93,420.625 | null | 27 | white | 19.597656 | 18 | 0.856934 | 0.807983 | 3 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 75 | 110 | 13.798828 | 96 | 8 | 38.19531 | 316.625 | 2.799805 | 4.299805 | 1.299805 | 142 | 7.439453 | null | null | null | null | 7 | SIP>=30 | 7 |
4,034 | 54.92999 | 1 | female | 0 | 6 | 472 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 7,007.297 | 4,616.1367 | null | 7 | white | 18.097656 | 9 | 0.709961 | 0.428955 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 6 | 87 | 5.799805 | 80 | 20 | 36.5 | null | 3.299805 | 0.099991 | 0.5 | 143 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,035 | 30.07799 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 37 | 209,604.625 | 147,492.5 | null | 57 | white | 42.398438 | 74 | 0.329956 | 0.214996 | 11 | 0 | 0 | no | 0 | 0 | no dnr | 6 | 129 | 6.899414 | 70 | 45 | 35.39844 | 283.3125 | 4.899414 | 44.09375 | 4.799805 | 151 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.212891 |
4,036 | 71.83795 | 1 | male | 0 | 6 | 264 | Lung Cancer | Cancer | 4 | 11 | $11-$25k | 0 | 4,572.348 | 3,001.1348 | null | 9 | white | 23.199219 | 26 | 0.541992 | 0.219971 | 1 | 1 | 0 | metastatic | 0.9 | 0.5 | no dnr | 6 | 99 | 5.599609 | 96 | 24 | 36.79688 | null | 3.399902 | 8.798828 | 0.799927 | 139 | null | null | null | null | null | 0 | null | 0 |
4,037 | 83.21997 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 118,611.438 | 71,038.4375 | null | 33 | white | 56.09375 | 75 | 0.003 | 0 | 16 | 0 | 0 | no | null | null | dnr after sadm | 2 | 28 | 11.398438 | 70 | 24 | 38.5 | 184 | null | 27 | 5.399414 | 152 | 7.379883 | null | null | null | null | null | <2 mo. follow-up | 2.294434 |
4,038 | 69.60999 | 1 | male | 0 | 10 | 174 | CHF | COPD/CHF/Cirrhosis | 2 | 3 | under $11k | 0 | 10,542.648 | 7,303.0156 | null | 25.5 | other | 19.097656 | 23 | 0.856934 | 0.764893 | 1 | 1 | 0 | no | null | null | no dnr | 10 | 80 | 6.899414 | 60 | 24 | 36.59375 | null | null | null | 2 | 143 | null | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
4,039 | 65.65399 | 0 | female | 0 | 17 | 1,478 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 76,424.625 | 45,303.5 | null | 25.666656 | white | 31.597656 | 39 | 0.610962 | 0.504883 | 5 | 0 | 0 | no | 0.5 | 0.45 | no dnr | 17 | 133 | 10.199219 | 11.398438 | 36 | 38.79688 | 137.5 | null | null | 0.799927 | 136 | 7.509766 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
4,040 | 72.797 | 0 | female | 0 | 76 | 1,478 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 168,419.875 | 104,400.125 | null | 39.5 | white | 33.09375 | 64 | 0.593994 | 0.485962 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 7 | 66 | 4.699219 | 130 | 10 | 35.89844 | 260 | 1.899902 | 12.898438 | 1.399902 | 149 | 7.449219 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.043945 |
4,041 | 77.46198 | 1 | male | 0 | 77 | 107 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $11-$25k | 44 | 237,865.75 | 151,713.375 | null | 41.25 | white | 30.796875 | 51 | 0.274963 | 0.166992 | 32 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 38 | 117 | 22.199219 | 118 | 10 | 35.39844 | 230 | 1.599854 | 0.5 | 3.599609 | 149 | 7.489258 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,042 | 71.06097 | 0 | female | 0 | 10 | 1,460 | COPD | COPD/CHF/Cirrhosis | 1 | 15 | null | 0 | 10,342.977 | 7,143 | null | 13.5 | white | 22.898438 | 25 | 0.796997 | 0.67395 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 10 | 90 | 10.699219 | 126 | 28 | 38 | 200 | null | null | 0.899902 | 134 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,043 | 68.73395 | 0 | female | 0 | 8 | 1,458 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 16,283.492 | 10,915.9531 | null | 16 | white | 28.199219 | 25 | 0.704956 | 0.615967 | 2 | 0 | 0 | no | null | null | no dnr | 8 | 97 | 3.799805 | 110 | 25 | 38.29688 | 126.51562 | null | null | 0.899902 | 139 | 7.439453 | null | null | null | 0 | null | null | 0.4948 |
4,044 | 40.92499 | 1 | female | 0 | 19 | 113 | MOSF w/Malig | ARF/MOSF | 1 | 12 | >$50k | 0 | 53,731.688 | 33,714.9375 | null | 29.333328 | white | 33.296875 | 31 | 0.440979 | 0.32196 | 5 | 0 | 0 | yes | null | null | no dnr | 19 | 63 | 11.699219 | 120 | 14 | 36.09375 | 74.28125 | null | 0.699951 | 0.599976 | 143 | 7.509766 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
4,045 | 61.74399 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | under $11k | 26 | 26,100.234 | 16,942.4375 | null | 27.5 | white | 21.5 | 28 | 0.787964 | 0.718994 | 1 | 0 | 0 | no | null | null | dnr after sadm | 6 | 137 | 12.599609 | 60 | 10 | 35 | 230 | 2.099609 | 0.099991 | 0.799927 | 147 | 7.5 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,046 | 61.405 | 1 | female | 0 | 5 | 784 | Lung Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 5,310.949 | 3,328.5 | null | 9 | white | 16.398438 | 12 | 0.727905 | 0.454956 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 120 | 20.597656 | 86 | 20 | 36.19531 | null | null | 0.299988 | 1.099854 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,047 | 25.00999 | 0 | male | 0 | 116 | 1,455 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | null | null | null | 19.25 | black | 22.398438 | 23 | 0.910889 | 0.87793 | 2 | 0 | 0 | no | null | null | no dnr | 116 | 69 | 12.298828 | 104 | 11 | 36.19531 | 352 | 2.399902 | 4 | 1.199951 | 137 | 7.359375 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,048 | 46.702 | 0 | female | 0 | 16 | 1,454 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | >$50k | 0 | 61,325.469 | 36,784.6875 | null | 25 | white | 17.597656 | 19 | 0.902954 | 0.868896 | 3 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 16 | 73 | 11.199219 | 74 | 24 | 38.29688 | 177.5 | 2.399902 | null | 1.299805 | 136 | 7.449219 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,049 | 78.98999 | 1 | female | 0 | 24 | 224 | COPD | COPD/CHF/Cirrhosis | 2 | 11 | under $11k | 0 | 40,662.344 | 26,147.1562 | null | 20 | white | 18.097656 | 26 | 0.772949 | 0.637939 | 1 | 0 | 0 | yes | 0.8 | 0.3 | no dnr | 24 | 65 | null | 96 | 8 | 36.29688 | 326.625 | null | null | 1.599854 | 139 | 7.369141 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,050 | 80.45197 | 1 | female | 1 | 19 | 19 | Colon Cancer | Cancer | 1 | 16 | null | 0 | 9,865.195 | 7,908.918 | null | 8.333328 | white | 34.195313 | 33 | 0.379944 | 0.090988 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 6 | 89 | 13.898438 | 86 | 20 | 36.39844 | null | 2.5 | 11.199219 | 1.199951 | 140 | null | null | null | null | null | null | <2 mo. follow-up | 3.102051 |
4,051 | 50.88599 | 1 | male | 1 | 10 | 10 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | 45,795.031 | 27,621.7188 | null | 49.5 | white | 27.796875 | 40 | 0.635986 | 0.532959 | 1 | 0 | 0 | yes | 0.2 | 0.2 | no dnr | 10 | 67 | 6.5 | 134 | 30 | 38.5 | 98.65625 | 2.199707 | 0.399963 | 0.799927 | 141 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.132813 |
4,052 | 68.39996 | 1 | male | 0 | 28 | 1,346 | MOSF w/Malig | ARF/MOSF | 1 | 7 | under $11k | 0 | 76,318.688 | 50,595.25 | null | 31.5 | black | 32.898438 | 56 | 0.381958 | 0.263977 | 7 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 28 | 121 | 3.399902 | 140 | 8 | 39.79688 | 167.5 | 1.5 | 0.5 | 2.199707 | 148 | 7.529297 | null | null | null | null | 5 | no(M2 and SIP pres) | 5 |
4,053 | 59.35898 | 1 | male | 0 | 11 | 499 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 19,767.641 | 13,664.2031 | null | 20.5 | white | 22.898438 | 18 | 0.858887 | 0.767944 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 11 | 113 | 13.5 | 110 | 24 | 36.5 | 220 | 3.199707 | 0.099991 | 0.699951 | 147 | 7.399414 | null | null | null | 0 | 4 | no(M2 and SIP pres) | 4 |
4,054 | 30.33299 | 1 | female | 1 | 43 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 0 | 191,009.625 | 119,011.625 | null | 37.5 | white | 28.699219 | 35 | 0.851929 | 0.800903 | 1 | 0 | 0 | no | 0.3 | 0.3 | dnr after sadm | 42 | 113 | 11.599609 | 130 | 28 | 39 | 132.71875 | 2 | 0.199982 | 0.599976 | 143 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,055 | 64.82996 | 1 | male | 0 | 62 | 724 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 213,969.625 | 141,854 | null | 39 | white | 29.097656 | 45 | 0.723999 | 0.638916 | 1 | 0 | 0 | no | null | null | no dnr | 62 | 145 | 5.599609 | 186 | 8 | 38 | 91 | null | 0.899902 | 0.699951 | 142 | 7.369141 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
4,056 | 68.75 | 1 | female | 1 | 10 | 10 | Coma | Coma | 2 | 8 | >$50k | 0 | 36,883.469 | 23,581.6719 | null | 36.5 | black | 25.796875 | 44 | 0.615967 | 0.552979 | 1 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 9 | 70 | 14.5 | 108 | 8 | 36.19531 | 423.3125 | 1.199951 | 0.299988 | 3 | 134 | 7.449219 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
4,057 | 83.79999 | 1 | male | 0 | 12 | 598 | Lung Cancer | Cancer | 2 | 16 | under $11k | 9 | 6,363.598 | 5,015.9961 | null | 4 | white | 18.199219 | 17 | 0.596924 | 0.277954 | 1 | 0 | 0 | metastatic | 0.75 | 0.5 | no dnr | 12 | 99 | 5.899414 | 80 | 16 | 36.19531 | null | 3.199707 | 0.5 | 1.199951 | 145 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,058 | 64.698 | 1 | male | 0 | 7 | 247 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 8,570.148 | 5,568.0586 | null | 9 | white | 11.699219 | 6 | 0.87793 | 0.723999 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 7 | 119 | 8.898438 | 60 | 24 | 36.29688 | null | 3.899902 | 0.599976 | 0.899902 | 136 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,059 | 29.30299 | 1 | female | 0 | 48 | 336 | MOSF w/Malig | ARF/MOSF | 2 | 12 | under $11k | 0 | 78,111.062 | 49,858.8438 | null | 20 | white | 37.09375 | 53 | 0.424988 | 0.304993 | 1 | 0 | 0 | yes | 0.2 | 0.2 | no dnr | 48 | 56 | 1.099854 | 134 | 38 | 39.29688 | 414.25 | 2.299805 | 5.899414 | 0.899902 | 135 | 7.419922 | null | null | null | null | 3 | SIP>=30 | 3 |
4,060 | 74.89697 | 1 | male | 1 | 100 | 100 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 202,651.25 | 132,608.375 | null | 26 | white | 32.296875 | 47 | 0.560913 | 0.447998 | 3 | 1 | 0 | no | 0.85 | 0.82 | no dnr | 100 | 103 | 14.5 | 55 | 32 | 38.5 | 108.15625 | null | null | 2.899902 | 134 | 7.459961 | null | null | null | null | null | null | 3.349609 |
4,061 | 60.44098 | 1 | male | 0 | 18 | 95 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 18 | >$50k | 0 | 16,636.344 | 11,546.3203 | null | 11.666664 | white | 23.5 | 43 | 0.72998 | 0.576904 | 1 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 14 | 63 | 7 | 74 | 22 | 36.19531 | 542.75 | 2.899902 | 1.299805 | 3.799805 | 132 | 7.269531 | null | null | null | 0 | 0 | null | 0 |
4,062 | 37.06198 | 1 | female | 0 | 48 | 436 | MOSF w/Malig | ARF/MOSF | 0 | 12 | null | 0 | 217,273.625 | 136,385 | null | 49.5 | white | 32.09375 | 65 | 0.505981 | 0.389954 | 3 | 0 | 0 | yes | 0.4 | 0.4 | dnr after sadm | 14 | 73 | 0.299988 | 144 | 32 | 39.29688 | 206.65625 | 1.699951 | 0.399963 | 1 | 154 | 7.379883 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,063 | 85.40997 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 19,168.188 | 12,807.8047 | null | 19 | black | 38.695313 | 64 | 0.257996 | 0.152985 | 8 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 4 | 70 | 42.695313 | 120 | 48 | 33.89844 | 112.23438 | null | 1.699951 | 0.799927 | 139 | 7.529297 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
4,064 | 35.71799 | 1 | female | 1 | 22 | 22 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 239,604.75 | 152,206.5 | null | 22.333328 | white | 29 | 60 | 0.424988 | 0.304993 | 45 | 0 | 0 | metastatic | 0.6 | 0.5 | dnr after sadm | 5 | 59 | 14.298828 | 144 | 9 | 36.79688 | 286.625 | 2.299805 | null | 5.5 | 134 | 7.289062 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
4,065 | 57.65097 | 1 | male | 0 | 5 | 274 | Lung Cancer | Cancer | 1 | 8 | under $11k | 0 | 6,005.699 | 3,721.2285 | null | 22 | white | 25.796875 | 10 | 0.517944 | 0.195984 | 1 | 0 | 0 | metastatic | 0.8 | 0.2 | no dnr | 5 | 83 | 15.599609 | 108 | 16 | 36.19531 | null | 3 | 0.299988 | 0.899902 | 135 | null | null | null | null | 3 | 1 | no(M2 and SIP pres) | 1 |
4,066 | 57.34399 | 0 | female | 0 | 5 | 1,441 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 4,947.398 | 3,368.4941 | null | 6 | white | 15 | 20 | 0.865967 | 0.777954 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 70 | 3.899902 | 74 | 20 | 36.79688 | null | 2.5 | 2.5 | 0.899902 | 138 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
4,067 | 79.05499 | 0 | female | 0 | 47 | 1,441 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 6 | under $11k | 0 | 60,292.469 | 38,939.5625 | null | 20 | black | 22.199219 | 42 | 0.758911 | 0.681885 | 3 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 47 | 87 | 9.5 | 114 | 28 | 37.79688 | 452.375 | 2.199707 | 1.099854 | 2 | 141 | 7.439453 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
4,068 | 52.38599 | 1 | male | 0 | 12 | 59 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 64,889.688 | 38,822.0312 | null | 30.5 | black | 31.796875 | 43 | 0.672974 | 0.577881 | 6 | 1 | 0 | no | null | null | no dnr | 12 | 65 | 11.798828 | 106 | 8 | 37.39844 | 110 | null | null | 2.899902 | 136 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.342285 |
4,069 | 19.92599 | 0 | male | 0 | 13 | 1,438 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 44 | 17,898.344 | 11,910.3516 | null | 19 | white | 22.597656 | 32 | 0.859985 | 0.81189 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 2 | 125 | 9.199219 | 136 | 44 | 38.69531 | 376.1875 | null | null | 0.699951 | 144 | 7.469727 | null | null | null | null | 7 | null | 7 |
4,070 | 57.72998 | 1 | male | 1 | 13 | 13 | Coma | Coma | 2 | 3 | under $11k | 100 | 125,777.25 | 86,312.9375 | null | 50 | black | 33.898438 | 50 | 0.017998 | 0.007 | 18 | 1 | 0 | no | null | null | dnr after sadm | 12 | 107 | 7.099609 | 136 | 8 | 35.89844 | 266.625 | 3.099609 | 7 | 4.699219 | 135 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.976074 |
4,071 | 73.13898 | 0 | female | 0 | 52 | 1,439 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | under $11k | 26 | 140,687.375 | 90,904.1875 | null | 30 | white | 22.296875 | 32 | 0.646973 | 0.545898 | 14 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 52 | 107 | 12.599609 | 116 | 10 | 38.69531 | 260 | 2.399902 | 0.699951 | 1.799805 | 146 | 7.40918 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,072 | 43.90399 | 0 | male | 0 | 14 | 1,437 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | >$50k | 0 | 63,622.125 | 38,628.3125 | null | 40.333313 | white | 22 | 20 | 0.870972 | 0.824951 | 3 | 0 | 0 | no | null | null | no dnr | 14 | 111 | 13.199219 | 68 | 10 | 38.29688 | 172.5 | null | 4.399414 | 1 | 134 | 7.399414 | null | null | null | null | null | no(M2 and SIP pres) | 1.974121 |
4,073 | 25.67 | 1 | male | 0 | 5 | 229 | Colon Cancer | Cancer | 1 | 16 | null | 0 | 3,895 | 2,701.5801 | null | 8 | white | 34.695313 | 19 | 0.575928 | 0.254944 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | no dnr | 5 | 81 | 3.699707 | 20 | 20 | 36.5 | null | 2.299805 | 0.299988 | 0.899902 | 139 | null | null | null | null | 1 | null | null | 1.1669 |
4,074 | 80.13696 | 1 | female | 0 | 30 | 621 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | $25-$50k | 9 | 54,550.188 | 36,936.5938 | null | 16.5 | white | 24.898438 | 31 | 0.650879 | 0.55188 | 5 | 0 | 0 | no | null | null | no dnr | 30 | 111 | 6.199219 | 56 | 26 | 36 | 157.5 | null | null | 0.799927 | 140 | 7.479492 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,075 | 70.57898 | 1 | male | 0 | 81 | 617 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 176,328 | 110,634.125 | null | 19.5 | white | 24.699219 | 30 | 0.712891 | 0.625 | 11 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 81 | 129 | 4.799805 | 68 | 9 | 36.69531 | 142 | 2 | 1.599854 | 0.899902 | 132 | 7.519531 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,076 | 86.35999 | 1 | female | 0 | 9 | 741 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 7,843.297 | 5,713.1523 | null | 11 | white | 18.898438 | 34 | 0.803955 | 0.682983 | 1 | 0 | 0 | no | null | null | dnr after sadm | 3 | 61 | 6.399414 | 56 | 16 | 35.69531 | 442.8125 | null | null | 1.099854 | 134 | 7.469727 | null | null | null | null | null | null | 3.556152 |
4,077 | 40.74698 | 1 | male | 0 | 9 | 46 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 7 | $11-$25k | 0 | 10,535.398 | 6,943.8008 | null | 9 | white | 22.398438 | 26 | 0.851929 | 0.756958 | 1 | 1 | 0 | no | 0.75 | 0.75 | no dnr | 9 | 103 | 4.399414 | 100 | 20 | 36.79688 | null | 2.5 | 1.5 | 1.5 | 127 | null | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
4,078 | 54.86398 | 0 | male | 0 | 14 | 1,434 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 9 | 16,353.844 | 10,914.2969 | null | 11.666664 | white | 27.699219 | 37 | 0.652954 | 0.475952 | 1 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 9 | 83 | 8.199219 | 106 | 24 | 36.19531 | 347.5625 | 2 | 11.199219 | 0.899902 | 130 | 7.529297 | null | null | null | 1 | 2 | null | 2 |
4,079 | 60.46799 | 1 | male | 1 | 5 | 5 | COPD | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 15,643.797 | 10,127.2734 | null | 35 | white | 34.695313 | 40 | 0.662964 | 0.487976 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 4 | 115 | 13 | 139 | 32 | 37.69531 | 256.625 | 1.299805 | 0.299988 | 1.399902 | 138 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 3.439941 |
4,080 | 57.49799 | 1 | female | 0 | 9 | 74 | Colon Cancer | Cancer | 1 | 9 | under $11k | 0 | 7,245.699 | 5,296.6523 | null | 9.5 | white | 34.59375 | 14 | 0.460999 | 0.146973 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 4 | 83 | 5.299805 | 94 | 20 | 36.19531 | null | 2.099609 | 0.199982 | 0.399963 | 136 | null | null | null | null | 3 | 3 | adl>=4 (>=5 if sur) | 3 |
4,081 | 68.45197 | 1 | female | 0 | 11 | 356 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 18,796.734 | 12,338.3828 | null | 9.5 | white | 18.699219 | 27 | 0.785889 | 0.549927 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 2 | 75 | 2.799805 | 60 | 10 | 38.29688 | 358.3125 | 3.399902 | null | 0.699951 | 134 | 7.5 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
4,082 | 39.67697 | 1 | male | 0 | 14 | 69 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 14,717.844 | 10,088.6016 | null | 7 | black | 22.5 | 45 | 0.855957 | 0.761963 | 1 | 0 | 0 | no | null | null | dnr after sadm | 5 | 88 | 6.199219 | 106 | 28 | 37.69531 | 285.6875 | 1.599854 | 5.399414 | 1 | 133 | 7.449219 | null | null | null | 0 | 7 | SIP>=30 | 7 |
4,083 | 60.81897 | 1 | male | 0 | 12 | 194 | CHF | COPD/CHF/Cirrhosis | 2 | 5 | under $11k | 0 | 25,250.438 | 15,713.0938 | null | 22 | other | 30.097656 | 31 | 0.716919 | 0.559937 | 2 | 0 | 0 | no | 0.5 | 0.2 | no dnr | 12 | 113 | 9.398438 | 64 | 22 | 36.79688 | 300 | 1.799805 | 0.699951 | 1.699951 | 130 | 7.439453 | null | null | null | 6 | 6 | SIP>=30 | 6 |
4,084 | 66.70795 | 1 | male | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | null | 41 | 125,133.938 | 77,324.25 | null | 50 | white | 34.09375 | 76 | 0.314941 | 0.201996 | 1 | 0 | 0 | yes | null | null | dnr after sadm | 22 | 56 | 15.199219 | 124 | 46 | 38.29688 | 116 | 2.699707 | 0.299988 | 9.599609 | 138 | 7.5 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
4,085 | 76.43298 | 1 | female | 0 | 28 | 197 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | $11-$25k | 0 | 38,696.375 | 27,296.1406 | null | 17.75 | white | 19.898438 | 29 | 0.802979 | 0.737915 | 3 | 0 | 0 | no | null | null | no dnr | 28 | 115 | 10.298828 | 66 | 6 | 38.39844 | 428.5625 | null | null | 6.899414 | 136 | 7.379883 | null | null | null | null | 1 | null | 1 |
4,086 | 47.21997 | 1 | male | 1 | 12 | 12 | Coma | Coma | 1 | 12 | null | 100 | 30,785.938 | 21,102.9844 | null | 31 | black | 19.097656 | 47 | 0.500977 | 0.429993 | 2 | 0 | 0 | no | 0.01 | 0.000001 | dnr after sadm | 7 | 150 | 7.099609 | 70 | 10 | 38.69531 | 388 | 1.799805 | 0.799927 | 5.299805 | 145 | 7.459961 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
4,087 | 43.05798 | 0 | female | 0 | 15 | 1,430 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | $25-$50k | 0 | 56,844.312 | 36,040.0625 | null | 21.333328 | hispanic | 29.5 | 44 | 0.745972 | 0.665894 | 11 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 15 | 118 | 20.796875 | 104 | 52 | 37.79688 | 200 | 2.299805 | 7.459961 | 1.199951 | 137 | 7.419922 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
4,088 | 88.94495 | 1 | female | 1 | 15 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 37 | 54,263.375 | 32,871.2812 | null | 36.666657 | white | 19.597656 | 31 | 0.666992 | 0.569946 | 1 | 0 | 0 | no | 0.8 | 0.6 | dnr after sadm | 12 | 107 | 6.799805 | 124 | 28 | 38.5 | 290 | 2.799805 | null | 0.899902 | 142 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,089 | 62.31598 | 1 | female | 0 | 12 | 147 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | null | 0 | 18,113.938 | 13,517.5469 | null | 10.5 | black | 21.097656 | 38 | 0.850952 | 0.799927 | 1 | 0 | 0 | no | 0.6 | 0.8 | no dnr | 12 | 117 | 24 | 104 | 32 | 36.39844 | 300 | 2.299805 | 0.399963 | 1.399902 | 141 | 7.439453 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
4,090 | 90.95996 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 26 | 18,570.594 | 12,917.6016 | null | 31 | white | 34.296875 | 65 | 0.213989 | 0.117996 | 8 | 0 | 0 | no | 0.3 | 0.3 | dnr after sadm | 1 | 107 | 8.398438 | 154 | 54 | 36.19531 | 105.70312 | null | null | 0.699951 | 151 | 7.419922 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
4,091 | 84.17798 | 1 | male | 0 | 4 | 225 | COPD | COPD/CHF/Cirrhosis | 2 | null | under $11k | 9 | 3,358.498 | 2,412.7949 | null | 9 | white | 27.796875 | 53 | 0.546997 | 0.348999 | 1 | 1 | 0 | no | null | null | no dnr | 4 | 93 | 29 | 120 | 28 | 36.19531 | 204.75 | null | 0.399963 | 1.799805 | 143 | 7.339844 | null | null | null | null | null | no(M2 and SIP pres) | 4.366211 |
4,092 | 66.00696 | 1 | male | 0 | 4 | 349 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 5 | under $11k | 0 | 3,166.85 | 2,237.1016 | null | 1 | black | 21.796875 | 35 | 0.7229 | 0.567993 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 100 | 7.599609 | 60 | 28 | 35.69531 | null | 2.199707 | 3.399902 | 0.799927 | 136 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
4,093 | 78.05896 | 1 | female | 1 | 25 | 25 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 44 | 171,969.5 | 105,160.625 | null | 34.25 | black | 38.5 | 68 | 0.056999 | 0.018997 | 11 | 1 | 0 | yes | 0.25 | 0.15 | dnr after sadm | 20 | 50 | 23 | 100 | 32 | 38 | 131.09375 | 3.299805 | 2.899902 | 6.199219 | 136 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 3.15332 |
4,094 | 85.06195 | 1 | female | 0 | 6 | 42 | CHF | COPD/CHF/Cirrhosis | 0 | 12 | under $11k | 0 | 4,003.299 | 2,980.1953 | null | 4 | white | 23.597656 | 31 | 0.73291 | 0.581909 | 1 | 0 | 0 | no | 0.5 | 0.45 | dnr after sadm | 3 | 107 | 8 | 52 | 36 | 35.39844 | null | 3.099609 | 0.799927 | 1 | 139 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
4,095 | 45.89499 | 1 | male | 0 | 8 | 377 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 18,237.391 | 13,212.0156 | null | 9.5 | white | 17.796875 | 17 | 0.915894 | 0.85791 | 2 | 0 | 0 | no | null | null | no dnr | 8 | 75 | 7.899414 | 76 | 16 | 35.79688 | 272 | null | null | 0.699951 | 134 | 7.479492 | null | null | null | 0 | null | null | 0.4948 |
4,096 | 36.64899 | 1 | female | 0 | 5 | 244 | Lung Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 5,317.398 | 3,209.3789 | null | 11 | white | 17.296875 | 12 | 0.763916 | 0.512939 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 70 | 8 | 104 | 20 | 36.79688 | null | null | 0.099991 | 0.699951 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.995361 |
4,097 | 57.81799 | 1 | male | 0 | 5 | 113 | Lung Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 5,601.098 | 3,373.2715 | null | 18 | white | 21.199219 | 16 | 0.635986 | 0.325989 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 104 | 11.298828 | 120 | 20 | 36.09375 | null | null | 0.199982 | 0.799927 | 141 | null | null | null | null | 2 | 4 | no(M2 and SIP pres) | 4 |
4,098 | 53.66998 | 0 | male | 0 | 13 | 1,422 | COPD | COPD/CHF/Cirrhosis | 1 | 8 | null | 0 | 18,630.891 | 12,266.3672 | null | 16 | white | 18.398438 | 20 | 0.916992 | 0.859985 | 1 | 0 | 0 | no | 0.99 | 0.95 | no dnr | 13 | 77 | 16.398438 | 72 | 24 | 35.5 | 240 | null | null | 1.199951 | 141 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,099 | 75.76196 | 1 | female | 0 | 26 | 137 | Colon Cancer | Cancer | 2 | 6 | null | 0 | 20,179.938 | 14,588.6016 | null | 12.5 | white | 24.296875 | 38 | 0.66394 | 0.362 | 1 | 0 | 0 | metastatic | 0.5 | 0.4 | no dnr | 26 | 130 | 10.298828 | 120 | 32 | 40.09375 | 423.75 | 3.299805 | 0.299988 | 0.799927 | 143 | 7.489258 | null | null | null | 1 | 1 | SIP>=30 | 1 |
4,100 | 60.38898 | 0 | male | 0 | 25 | 1,422 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 0 | 61,711.688 | 42,741.7188 | null | 15 | white | 20.5 | 20 | 0.838989 | 0.783936 | 4 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 25 | 125 | 18.597656 | 124 | 9 | 39 | 348 | 2.699707 | null | 0.899902 | 141 | 7.5 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.